AGAM Aga Medical Holdings Com (MM)

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of AGA Medical Holdings, Inc. (“AGA” or the “Company”) (Nasdaq: AGAM) concerning the sale of the Company to Carlisle Companies Inc. for $20.80 in an even split of cash and stock for each share of common stock owned in a transaction valued at approximately $1.3 billion. The transaction is expected to close by the end 2010.

The investigation is focused on the potential unfairness of the deal price to AGA shareholders, the process by which the Board of Directors considered the transaction, and potential conflicts of interests among AGA Board members. Certain shareholders affiliated with the private equity firm that took AGA public, which own 44% of all outstanding shares, and AGA co-founder Frank Gougeon, holder of 19% of all outstanding shares, have already agreed to tender their shares in favor of the merger.

If you are interested in discussing your rights as an AGA shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Aga Medical Holdings Com (MM) (NASDAQ:AGAM)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Aga Medical Holdings Com (MM) (NASDAQ:AGAM)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024